Suppression of nonhomologous end joining repair by overexpression of HMGA2
- PMID: 19549901
- PMCID: PMC2737594
- DOI: 10.1158/0008-5472.CAN-08-4833
Suppression of nonhomologous end joining repair by overexpression of HMGA2
Abstract
Understanding the molecular details associated with aberrant high mobility group A2 (HMGA2) gene expression is key to establishing the mechanism(s) underlying its oncogenic potential and effect on the development of therapeutic strategies. Here, we report the involvement of HMGA2 in impairing DNA-dependent protein kinase (DNA-PK) during the nonhomologous end joining (NHEJ) process. We showed that HMGA2-expressing cells displayed deficiency in overall and precise DNA end-joining repair and accumulated more endogenous DNA damage. Proper and timely activation of DNA-PK, consisting of Ku70, Ku80, and DNA-PKcs subunits, is essential for the repair of DNA double strand breaks (DSB) generated endogenously or by exposure to genotoxins. In cells overexpressing HMGA2, accumulation of histone 2A variant X phosphorylation at Ser-139 (gamma-H2AX) was associated with hyperphosphorylation of DNA-PKcs at Thr-2609 and Ser-2056 before and after the induction of DSBs. Also, the steady-state complex of Ku and DNA ends was altered by HMGA2. Microirradiation and real-time imaging in living cells revealed that HMGA2 delayed the release of DNA-PKcs from DSB sites, similar to observations found in DNA-PKcs mutants. Moreover, HMGA2 alone was sufficient to induce chromosomal aberrations, a hallmark of deficiency in NHEJ-mediated DNA repair. In summary, a novel role for HMGA2 to interfere with NHEJ processes was uncovered, implicating HMGA2 in the promotion of genome instability and tumorigenesis.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2737594/bin/nihms119606f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2737594/bin/nihms119606f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2737594/bin/nihms119606f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2737594/bin/nihms119606f4.gif)
Comment in
-
Comment re: HMGA2 is a negative regulator of DNA-PK pathway.Cancer Res. 2010 Feb 15;70(4):1742; author reply 1742. doi: 10.1158/0008-5472.CAN-09-3081. Epub 2010 Feb 9. Cancer Res. 2010. PMID: 20145117 No abstract available.
Similar articles
-
The N-terminal region of the DNA-dependent protein kinase catalytic subunit is required for its DNA double-stranded break-mediated activation.J Biol Chem. 2013 Mar 8;288(10):7037-46. doi: 10.1074/jbc.M112.434498. Epub 2013 Jan 15. J Biol Chem. 2013. PMID: 23322783 Free PMC article.
-
Biochemical evidence for Ku-independent backup pathways of NHEJ.Nucleic Acids Res. 2003 Sep 15;31(18):5377-88. doi: 10.1093/nar/gkg728. Nucleic Acids Res. 2003. PMID: 12954774 Free PMC article.
-
The mutagenic potential of non-homologous end joining in the absence of the NHEJ core factors Ku70/80, DNA-PKcs and XRCC4-LigIV.Mutagenesis. 2007 May;22(3):217-33. doi: 10.1093/mutage/gem007. Epub 2007 Mar 7. Mutagenesis. 2007. PMID: 17347130
-
Mechanisms of DNA double strand break repair and chromosome aberration formation.Cytogenet Genome Res. 2004;104(1-4):14-20. doi: 10.1159/000077461. Cytogenet Genome Res. 2004. PMID: 15162010 Review.
-
Coordination of DNA-PK activation and nuclease processing of DNA termini in NHEJ.Antioxid Redox Signal. 2011 Jun 15;14(12):2531-43. doi: 10.1089/ars.2010.3368. Epub 2010 Dec 2. Antioxid Redox Signal. 2011. PMID: 20698792 Free PMC article. Review.
Cited by
-
Pancreatic cancer cells hijack tumor suppressive microRNA-26a to promote radioresistance and potentiate tumor repopulation.Heliyon. 2024 May 15;10(10):e31346. doi: 10.1016/j.heliyon.2024.e31346. eCollection 2024 May 30. Heliyon. 2024. PMID: 38807872 Free PMC article.
-
Adjuvant Chemotherapy With or Without Radiotherapy for Resected Pancreatic Cancer After Multiagent Neoadjuvant Chemotherapy.Ann Surg Oncol. 2024 Aug;31(8):4966-4975. doi: 10.1245/s10434-024-15157-4. Epub 2024 May 24. Ann Surg Oncol. 2024. PMID: 38789615
-
TI17, a novel compound, exerts anti-MM activity by impairing Trip13 function of DSBs repair and enhancing DNA damage.Cancer Med. 2023 Dec;12(23):21321-21334. doi: 10.1002/cam4.6706. Epub 2023 Nov 9. Cancer Med. 2023. PMID: 37942576 Free PMC article.
-
Aberrant HMGA2 Expression Sustains Genome Instability That Promotes Metastasis and Therapeutic Resistance in Colorectal Cancer.Cancers (Basel). 2023 Mar 13;15(6):1735. doi: 10.3390/cancers15061735. Cancers (Basel). 2023. PMID: 36980621 Free PMC article. Review.
-
Effects of HMGA2 on the epithelial-mesenchymal transition-related genes in ACHN renal cell carcinoma cells-derived xenografts in nude mice.BMC Cancer. 2022 Apr 19;22(1):421. doi: 10.1186/s12885-022-09537-w. BMC Cancer. 2022. PMID: 35439951 Free PMC article.
References
-
- Cleynen I, Van de Ven WJ. The HMGA proteins: a myriad of functions (Review) Int J Oncol. 2008;32:289–305. - PubMed
-
- Zhou X, Benson KF, Ashar HR, Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature. 1995;376:771–4. - PubMed
-
- Monzen K, Ito Y, Naito AT, et al. A crucial role of a high mobility group protein HMGA2 in cardiogenesis. Nat Cell Biol. 2008;10:567–74. - PubMed
-
- Fedele M, Visone R, De Martino I, et al. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell. 2006;9:459–71. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DE014183/DE/NIDCR NIH HHS/United States
- CA 50519/CA/NCI NIH HHS/United States
- T32 CA009659/CA/NCI NIH HHS/United States
- R01 CA072767/CA/NCI NIH HHS/United States
- R29 CA072767-05/CA/NCI NIH HHS/United States
- R01 DE014183-05/DE/NIDCR NIH HHS/United States
- R37 CA050519/CA/NCI NIH HHS/United States
- CA 72767/CA/NCI NIH HHS/United States
- R01 DE 10742/DE/NIDCR NIH HHS/United States
- DE 14183/DE/NIDCR NIH HHS/United States
- R01 CA050519-11/CA/NCI NIH HHS/United States
- R01 CA050519/CA/NCI NIH HHS/United States
- R01 DE010742-09/DE/NIDCR NIH HHS/United States
- R01 DE010742/DE/NIDCR NIH HHS/United States
- T32 CA 09659/CA/NCI NIH HHS/United States
- R29 CA072767/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials